BioNTech Defends Cancer Vaccine Patent At EPO
BioNTech has fought off the latest challenge to a cancer vaccine patent that it holds jointly with researchers at a German university, convincing a European appeals panel that the treatment is...To view the full article, register now.
Already a subscriber? Click here to view full article